Olivia Kieffer, PA
Payments from drug & device makers
Across 78 payments — averaging $22.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$268
- Sanofi$206
- GSK$177
- CSL Behring$164
- Blueprint Medicines Corporation$132
- Regeneron Healthcare Solutions, Inc.$115
- plus $695 from 15 others
What the payments were for
- Consulting fees$815%
- Food & beverage$1,67695%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $268 |
| Sanofi | 9 | $206 |
| GSK | 10 | $177 |
| CSL Behring | 6 | $164 |
| Blueprint Medicines Corporation | 5 | $132 |
| Regeneron Healthcare Solutions, Inc. | 4 | $115 |
| Genentech USA, Inc. | 4 | $85 |
| Pharming Healthcare, Inc. | 4 | $83 |
| ADMA Biomanufacturing LLC | 4 | $81 |
| Tersera Therapeutics LLC | 2 | $61 |
| Kaleo, Inc. | 3 | $55 |
| Novartis | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Phadia US Inc. | 2 | $45 |
| Octapharma USA, Inc. | 2 | $34 |
| Exact Sciences | 2 | $29 |
| Amgen | 1 | $28 |
| Biocryst US Sales Co., LLC | 1 | $27 |
| Grifols USA, LLC | 1 | $21 |
| Alk-abello, Inc | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
How this compares
$1,757 in reported general payments places this provider in the 70th percentile of 748 medical providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $382 |
| Prednisone | 13 | $10 |
Paid to pharmacies, not to this prescriber.
Other medical in Mesa
- Anngela EdkinsMesa$16K
- Tasha MackMesa$14K
- Dana HoffmanMesa$14K
- Laurie PetersonMesa$12K
- Robert CasquejoScottsdale$474K
- Andrew HicksPeoria$460K
- Darren WestScottsdale$206K
- Linda MoorsTucson$122K
- Jamie WystrachScottsdale$79K
- Scott YoungPhoenix$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.